Nonprotective responses to pediatric vaccines occur in children who are otitis prone

Michael E Pichichero1, Janet R Casey, Anthony Almudevar

  • 1From the *Center for Infectious Disease and Immunology, Research Institute, Rochester General Hospital; †Legacy Pediatrics; and ‡Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY.

Insights

Children with recurrent otitis media (sOP) show reduced antibody responses to routine pediatric vaccines, including diphtheria, tetanus, and hepatitis B. Many sOP children fail to reach protective antibody levels by 24 months.

Area of Science:

  • Pediatric immunology
  • Vaccinology
  • Infectious disease research

Background:

  • Recurrent otitis media (sOP) is associated with impaired antibody responses to specific bacterial antigens.
  • Previous studies indicated a lack of response to vaccine candidate antigens in sOP children.
  • This study investigates antibody responses to routine pediatric vaccinations in sOP children.

Purpose of the Study:

  • To determine if children with stringently-defined otitis prone (sOP) also fail to develop adequate antibody responses to routine pediatric vaccinations.
  • To assess IgG concentrations against common vaccine antigens in sOP versus non-sOP children.

Main Methods:

  • Analysis of 140 sera from children aged 6-24 months.
  • Comparison of IgG concentrations for diphtheria, tetanus, pertussis, hepatitis B, polio, H. influenzae type b, and Streptococcus pneumoniae vaccines between sOP (n=34) and non-sOP (n=34) children.
  • Use of generalized estimating equations for statistical analysis.

Main Results:

  • sOP children exhibited significantly decreased IgG protective titers to diphtheria, tetanus, pertussis, filamentous hemagglutinin, pertactin, hepatitis B, polio 3, and Streptococcus pneumoniae 23F.
  • A substantial proportion of sOP children had nonprotective antibody levels persisting up to 24 months of age.
  • No significant differences were observed for polio 1, 2, H. influenzae type b capsule, or Streptococcus pneumoniae 6B and 14.

Conclusions:

  • Stringently-defined otitis prone (sOP) children may not achieve protective antibody concentrations following standard vaccination schedules.
  • This impaired response highlights potential challenges in vaccine efficacy for this pediatric population.
  • Further research may be needed to optimize vaccination strategies for sOP children.
Abstract

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Vaccinations01:51

Vaccinations

Overview
44.3K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
414
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
12.3K